287 related articles for article (PubMed ID: 15722032)
1. Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.
Carmona R; Pérez-Alvarez L; Muñoz M; Casado G; Delgado E; Sierra M; Thomson M; Vega Y; Vázquez de Parga E; Contreras G; Medrano L; Nájera R
J Clin Virol; 2005 Mar; 32(3):248-53. PubMed ID: 15722032
[TBL] [Abstract][Full Text] [Related]
2. Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance.
Chong H; Xu S; Zhang C; Nie J; Wang Y
J Clin Virol; 2009 Jul; 45(3):255-8. PubMed ID: 19487156
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 gp 41 mutations in proviral DNA among antiretroviral treatment-naive individuals from India.
Sen S; Tripathy SP; Sahni AK; Gupta RM; Kapila K; Chopra GS; Chimanpure VM; Patil AA; Paranjape RS
AIDS Res Hum Retroviruses; 2009 May; 25(5):521-3. PubMed ID: 19400735
[TBL] [Abstract][Full Text] [Related]
4. Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1.
Pérez-Alvarez L; Carmona R; Ocampo A; Asorey A; Miralles C; Pérez de Castro S; Pinilla M; Contreras G; Taboada JA; Nájera R
J Med Virol; 2006 Feb; 78(2):141-7. PubMed ID: 16372284
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of primary Enfuvirtide (ENF) resistance-associated mutations in HIV-1-infected patients in Hong Kong.
Leung PH; Chen JH; Wong KH; Chan KC; Lam HY; Cheng VC; Yuen KY; Yam WC
J Clin Virol; 2010 Mar; 47(3):273-5. PubMed ID: 20116329
[TBL] [Abstract][Full Text] [Related]
6. Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART.
Oliveira AC; Martins AN; Pires AF; Arruda MB; Tanuri A; Pereira HS; Brindeiro RM
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):193-8. PubMed ID: 19239358
[TBL] [Abstract][Full Text] [Related]
7. Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
Menzo S; Castagna A; Monachetti A; Hasson H; Danise A; Carini E; Bagnarelli P; Lazzarin A; Clementi M
New Microbiol; 2004 Apr; 27(2 Suppl 1):51-61. PubMed ID: 15646065
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique.
Ismael N; Bila D; Mariani D; Vubil A; Mabunda N; Abreu C; Jani I; Tanuri A
AIDS Res Hum Retroviruses; 2014 Jun; 30(6):603-9. PubMed ID: 24188582
[TBL] [Abstract][Full Text] [Related]
10. Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.
Loutfy MR; Raboud JM; Montaner JS; Antoniou T; Wynhoven B; Smaill F; Rouleau D; Gill J; Schlech W; Brumme ZL; Mo T; Gough K; Rachlis A; Harrigan PR; Walmsley SL
Antiviral Res; 2007 Jul; 75(1):58-63. PubMed ID: 17196268
[TBL] [Abstract][Full Text] [Related]
11. Short communication: high polymorphism rates in the HR1 and HR2 gp41 and presence of primary resistance-related mutations in HIV type 1 circulating in Brazil: possible impact on enfuvirtide efficacy.
Teixeira C; de Sá-Filho D; Alkmim W; Janini LM; Diaz RS; Komninakis S
AIDS Res Hum Retroviruses; 2010 Mar; 26(3):307-11. PubMed ID: 20334566
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC.
Araújo LA; Junqueira DM; de Medeiros RM; Matte MC; Almeida SE
J Clin Virol; 2012 May; 54(1):6-10. PubMed ID: 22336085
[TBL] [Abstract][Full Text] [Related]
13. Genotypic analysis of the gp41 HR1 region from HIV-1 isolates from enfuvirtide-treated and untreated patients.
Pessoa LS; Valadão AL; Abreu CM; Calazans AR; Martins AN; Azevedo SS; Couto-Fernandez JC; Azevedo MC; Tanuri A
J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3():S197-201. PubMed ID: 21857318
[TBL] [Abstract][Full Text] [Related]
14. Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
Covens K; Kabeya K; Schrooten Y; Dekeersmaeker N; Van Wijngaerden E; Vandamme AM; De Wit S; Van Laethem K
J Clin Virol; 2009 Apr; 44(4):325-8. PubMed ID: 19237313
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
Sá-Ferreira JA; Brindeiro PA; Chequer-Fernandez S; Tanuri A; Morgado MG
Transfusion; 2007 Jan; 47(1):97-102. PubMed ID: 17207236
[TBL] [Abstract][Full Text] [Related]
16. Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.
Aquaro S; D'Arrigo R; Svicher V; Perri GD; Caputo SL; Visco-Comandini U; Santoro M; Bertoli A; Mazzotta F; Bonora S; Tozzi V; Bellagamba R; Zaccarelli M; Narciso P; Antinori A; Perno CF
J Antimicrob Chemother; 2006 Oct; 58(4):714-22. PubMed ID: 16891628
[TBL] [Abstract][Full Text] [Related]
17. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
[TBL] [Abstract][Full Text] [Related]
18. Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
Cabrera C; Marfil S; García E; Martinez-Picado J; Bonjoch A; Bofill M; Moreno S; Ribera E; Domingo P; Clotet B; Ruiz L
AIDS; 2006 Oct; 20(16):2075-80. PubMed ID: 17053353
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of drug resistance-related polymorphisms in treatment-naive individuals infected with nonsubtype B HIV type 1 in Cameroon.
Youngpairoj AS; Alemnji GA; Eno LT; Lyonga EJ; Eloundou MA; Shanmugam V; Mpoudi EN; Folks TM; Kalish ML; Pieniazek D; Fonjungo PN
AIDS Res Hum Retroviruses; 2012 Jul; 28(7):675-84. PubMed ID: 21923557
[TBL] [Abstract][Full Text] [Related]
20. Genetic and structural analysis of HIV-1 Rev responsive element related to V38A and T18A enfuvirtide resistance mutations.
Dimonte S; Mercurio F; Svicher V; Perno CF; Ceccherini-Silberstein F
Intervirology; 2012; 55(5):385-90. PubMed ID: 22188777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
